Advanced Enzyme Technologies' Q1 FY 2025-26 Quarterly Results
- 03 Aug 2025
Result Summary
- Advanced Enzyme Technologies Ltd reported a 16.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 20.6%.
- Its expenses for the quarter were up by 24.2% QoQ and 23.9% YoY.
- The net profit increased 35.4% QoQ and increased 15.6% YoY.
- The earnings per share (EPS) of Advanced Enzyme Technologies Ltd stood at 3.6 during Q1 FY 2025-26.
Financial Statments for Q1 FY 2025-26
Total Income | 194.76 | 167.31 | 161.52 | 16.4% | 20.6% |
Total Expenses | 139.86 | 112.58 | 112.84 | 24.2% | 23.9% |
Profit Before Tax | 54.90 | 39.61 | 48.67 | 38.6% | 12.8% |
Tax | 14.46 | 9.74 | 13.70 | 48.5% | 5.5% |
Profit After Tax | 40.44 | 29.87 | 34.97 | 35.4% | 15.6% |
Earnings Per Share | 3.60 | 2.50 | 3.00 | 44.0% | 20.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Advanced Enzyme Technologies Ltd is a leading enzyme company that specializes in the research, development, and manufacturing of enzyme solutions. It operates in the biotechnology industry, focusing on products that enhance the nutritional value and processing efficiency for industries such as pharmaceuticals, food, and animal nutrition. The company's product portfolio includes a wide range of enzymes used for digestive health, food processing, and industrial applications. Major developments in recent times include innovations in enzyme applications and expansion into new markets. However, specific recent developments are not available in the provided data.
Revenue
During the first quarter of fiscal year 2026 (Q1FY26), Advanced Enzyme Technologies Ltd reported total income of ₹194.76 crores. This represents a quarter-over-quarter (QoQ) increase of 16.4% from ₹167.31 crores reported in Q4FY25. Additionally, there was a year-over-year (YoY) increase of 20.6% compared to the ₹161.52 crores recorded in Q1FY25. These increases in total income indicate a growth trajectory when comparing both sequential and annual periods.
Profitability
The company's profitability metrics for Q1FY26 highlight a profit before tax of ₹54.90 crores, up 38.6% QoQ from ₹39.61 crores in Q4FY25, and a YoY increase of 12.8% from ₹48.67 crores in Q1FY25. The tax expense for the quarter was ₹14.46 crores, rising 48.5% QoQ and 5.5% YoY. The profit after tax stood at ₹40.44 crores, reflecting a 35.4% increase QoQ and a 15.6% rise YoY. Earnings per share were ₹3.60, showcasing a significant QoQ growth of 44.0% and a YoY increase of 20.0%.
Operating Metrics
Total expenses for Q1FY26 were ₹139.86 crores, marking a 24.2% QoQ increase from ₹112.58 crores in Q4FY25, and a 23.9% YoY increase from ₹112.84 crores in Q1FY25. The growth in expenses is observed alongside the income, indicating expanded operational activity. The significant rise in expenses, along with the increase in total income and profitability metrics, suggests active business operations and potentially increased production or sales efforts within the company. Specific financial ratios like P/E ratio, debt-to-equity ratio, or current ratio are not provided in the data, thus cannot be calculated.
FAQs
Advanced Enzyme Technologies Ltd announced its Q1 FY 2025-26 results on 3 August, 2025.
Advanced Enzyme Technologies Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Advanced Enzyme Technologies Ltd Q1 FY 2025-26 results include:
- Revenue: ₹194.76 crore
- Net Profit: ₹40.44 crore
- EBITDA: ₹65.28 crore
- Year-over-Year Growth: 20.6%
- Quarter-over-Quarter Growth: 16.4%
Advanced Enzyme Technologies Ltd reported a net profit of ₹40.44 crore in Q1 FY 2025-26, reflecting a 15.6% year-over-year growth.
Advanced Enzyme Technologies Ltd posted a revenue of ₹194.76 crore in Q1 FY 2025-26.